Sutradhar, P. R., Sultana, N., & Nessa, A. miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD). Wiley.
Chicago Style (17th ed.) CitationSutradhar, Parthana Rani, Nahida Sultana, and Afzalun Nessa. MiRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) Due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD). Wiley.
MLA (9th ed.) CitationSutradhar, Parthana Rani, et al. MiRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) Due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD). Wiley.
Warning: These citations may not always be 100% accurate.